[go: up one dir, main page]

Latest News for: xeri

Edit

Notice of Proposed Sale of Securities (Form 144) (Xeris Biopharma Holdings Inc)

Public Technologies 07 Jul 2026
) ... You can access the original document here ... Disclaimer. Xeris Biopharma Holdings Inc.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Xeris Biopharma Holdings Inc)

Public Technologies 07 Jul 2026
) FORM 4. Check this box if no longer subject to Section 16 ... See Instruction 1(b) ... 2 ... Xeris Biopharma Holdings, Inc ... C/O XERIS BIOPHARMA HOLDINGS, INC., 1375 WEST FULTON STREET, SUITE 1300 3 ... C/O XERIS BIOPHARMA HOLDINGS, INC ... Xeris Biopharma Holdings Inc.
Edit

CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Business Wire 03 Jul 2026
XERIS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Xeris Biopharma Holdings, Inc ...
Edit

CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Xeris Biopharma Holdings Inc)

Public Technologies 03 Jul 2026
XERIS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4). Xeris Biopharma Holdings, Inc ... All equity awards are subject to the terms and conditions of Xeris' Inducement Equity Plan and forms of award agreements covering the grants.
Edit

Initial Statement of Beneficial Ownership (Form 3) (Xeris Biopharma Holdings Inc)

Public Technologies 03 Jul 2026
) FORM 3. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C ... 0.5 ... 2 ... Xeris Biopharma Holdings, Inc ... C/O XERIS BIOPHARMA HOLDINGS, INC., 1375 WEST FULTON STREET, SUITE 1300 4 ... 5 ... C/O XERIS BIOPHARMA HOLDINGS, INC ... Xeris Biopharma Holdings Inc.
Edit

Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Xeris Biopharma Holdings Inc)

Public Technologies 02 Jul 2026
2, 2026-- Xeris Biopharma Holdings, Inc ... The restricted stock units will vest over a period of three years in equal annual installments and are subject to the employees' continued employment with Xeris or one of its subsidiaries ... About Xeris.
Edit

Xeris Announces Updates to Its Board of Directors (Form 8-K) (Xeris Biopharma Holdings Inc)

Public Technologies 30 Jun 2026
) Xeris Announces Updates to Its Board of Directors ... CHICAGO, IL - Xeris Biopharma Holdings, Inc ... "I am honored to have been named chairman of Xeris," said Mr ... About Xeris. Xeris (Nasdaq ... Xeris has three commercially available products.
Edit

Xeris Announces Updates to Its Board of Directors

Business Wire 30 Jun 2026
CHICAGO--(BUSINESS WIRE)--Xeris Announces Updates to Its Board of Directors ... .
Edit

Xeris Biopharma Announces Notice of Allowance From U.S. Patent and Trademark Office for New Patent ...

Norfolk Daily News 12 Jun 2026
Patent expected to provide intellectual property protection for Keveyis through 2039 Reinforces Xeris’ commitment to ... .
Edit

XERIS BIOPHARMA ANNOUNCES PRIVATE EXCHANGE OF CONVERTIBLE NOTES (Form 8-K) (Xeris Biopharma Holdings Inc)

Public Technologies 11 Jun 2026
) XERIS BIOPHARMA ANNOUNCES PRIVATE EXCHANGE OF CONVERTIBLE NOTES ... CHICAGO, IL; June 11, 2026 - Xeris Biopharma Holdings, Inc ... Following the closing of the exchanges, Xeris will have $10.5 million in aggregate principal amount of the Notes outstanding.
Edit

Xeris Biopharma Announces Private Exchange of Convertible Notes

Business Wire 11 Jun 2026
CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc ... Pursuant to the exchange agreements, Xeris ...
Edit

The AMF has decided to withdraw the authorisation of the asset management company Xerys Invest (AMF - Financial Markets Authority of the French Republic)

Public Technologies 10 Jun 2026
... (AMF) has decided to withdraw the authorisation of the asset management company Xerys Invest in view of its situation.
Edit

Proxy Results (Form 8-K) (Xeris Biopharma Holdings Inc)

Public Technologies 05 Jun 2026
) Item 5.07 Submission of Matters to a Vote of Security Holders. On June 4, 2026, Xeris Biopharma Holdings, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting") ... Xeris Biopharma Holdings Inc.
Edit

Xeris Biopharma: Q1 Earnings Snapshot

Clinton Herald 08 May 2026
CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Thursday reported first-quarter net income of $2.2 million ... .
Edit

Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) (Xeris Biopharma Holdings Inc)

Public Technologies 08 May 2026
along with its subsidiaries, is referenced herein as the "Company," "Xeris," "Xeris Biopharma," "we" or "our." Throughout this document, unless ...

Article Search

tools
×
×
×
×